---
title: "ES: Q2 2026 recurring EPS met guidance; Aquarion sale boosted liquidity; 2026 EPS guidance lowered"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294417827.md"
description: "Q2 2026 recurring EPS was $0.87, in line with guidance, but GAAP EPS fell due to non-recurring charges. The Aquarion sale generated $1.7B in cash, supporting debt reduction and credit metrics. Revised 2026 EPS guidance is $4.57–$4.72, with long-term growth targets reaffirmed.Original document: Eversource Energy (D/B/A) [ES] Slides Release — Jul. 31 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-30T21:17:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294417827.md)
  - [en](https://longbridge.com/en/news/294417827.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294417827.md)
generator: "portal-rs"
---

# ES: Q2 2026 recurring EPS met guidance; Aquarion sale boosted liquidity; 2026 EPS guidance lowered

Q2 2026 recurring EPS was $0.87, in line with guidance, but GAAP EPS fell due to non-recurring charges. The Aquarion sale generated $1.7B in cash, supporting debt reduction and credit metrics. Revised 2026 EPS guidance is $4.57–$4.72, with long-term growth targets reaffirmed.

Original document: Eversource Energy (D/B/A) \[ES\] Slides Release — Jul. 31 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ES.US](https://longbridge.com/en/quote/ES.US.md)

## Related News & Research

- [AIIR: H1'26 saw resilient revenue and stable Adjusted EBITDA amid disruption, with growth set to accelerate](https://longbridge.com/en/news/296476265.md)
- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)
- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)
- [DE: 3Q 2026 saw sales and profit growth, but FY 2026 guidance signals industry headwinds](https://longbridge.com/en/news/296475895.md)
- [Algorhythm Holdings Reports Second Quarter 2026 Financial Results](https://longbridge.com/en/news/296124832.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**